Company logo

GRAY - Graybug Vision, Inc.

NASDAQ -> Healthcare -> Biotechnology
Redwood City, United States
Type: Equity

GRAY price evolution
GRAY
(in millions $) 30 Sep 2022 30 Jun 2022 31 Mar 2022 31 Dec 2021
Current assets
Cash $10.17 $13.87 $8.36 $13.36
Short term investments $33.46 $36.82 $46.92 $50.31
Net receivables
Inventory
Total current assets $45.07 $51.73 $58.22 $67.08
Long term investments
Property, plant & equipment $0.29 $2.29 $2.33 $1.98
Goodwill & intangible assets
Total noncurrent assets $0.29 $2.29 $2.36 $2.01
Total investments $33.46 $36.82 $46.92 $50.31
Total assets $45.36 $54.02 $60.59 $69.09
Current liabilities
Accounts payable $0.5 $1.01 $0.54 $0.53
Deferred revenue
Short long term debt $0.3 $0.4 $0.39
Total current liabilities $3.76 $4.33 $4.23 $4.06
Long term debt $0.1
Total noncurrent liabilities $0.1 $0.01
Total debt $0.3 $0.4 $0.49
Total liabilities $3.76 $4.33 $4.33 $4.07
Shareholders' equity
Retained earnings -$197.39 -$187.58 -$179.34 -$169.19
Other shareholder equity -$0.12 -$0.18 -$0.18 -$0.02
Total shareholder equity $41.6 $49.69 $56.26 $65.02
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 30 Dec 2018
Current assets
Cash $13.36 $33.42 $15.87 $12.83
Short term investments $50.31 $61.62 $20.09
Net receivables $0.02
Inventory
Total current assets $67.08 $99.24 $36.27 $13.45
Long term investments
Property, plant & equipment $1.98 $1.95 $1.98 $1.51
Goodwill & intangible assets
Total noncurrent assets $2.01 $2.55 $4.39 $4.37
Total investments $50.31 $61.62 $20.09
Total assets $69.09 $101.79 $40.66 $17.81
Current liabilities
Accounts payable $0.53 $2.51 $4.64 $2.52
Deferred revenue
Short long term debt
Total current liabilities $4.06 $7 $12.25 $5.79
Long term debt
Total noncurrent liabilities $0.01 $0.01 $131.36 $78.81
Total debt
Total liabilities $4.07 $7.01 $143.61 $5.79
Shareholders' equity
Retained earnings -$169.19 -$133.37 -$105.84 -$68.8
Other shareholder equity -$0.02 -$0 $0
Total shareholder equity $65.02 $94.79 -$102.95 -$66.79
(in millions $) 30 Sep 2022 30 Jun 2022 31 Mar 2022 31 Dec 2021
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development $3.25 $4.06 $6.06 $4.27
Selling, general & administrative $4.3 $4.24 $4.13 $4.43
Total operating expenses $9.98 $8.3 $10.18 $8.7
Operating income -$9.98 -$8.3 -$10.18 -$8.7
Income from continuing operations
EBIT -$9.81 -$8.24 -$10.15 -$8.68
Income tax expense
Interest expense
Net income
Net income -$9.81 -$8.24 -$10.15 -$8.68
Income (for common shares) -$9.81 -$8.24 -$10.15 -$8.68
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 30 Dec 2018
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development $18.9 $20.96 $30.58 $22.97
Selling, general & administrative $17.04 $8.87 $6.92 $5.6
Total operating expenses $35.95 $29.83 $37.5 $28.57
Operating income -$35.95 -$29.83 -$37.5 -$28.57
Income from continuing operations
EBIT -$35.82 -$27.53 -$37.04 -$28.57
Income tax expense
Interest expense
Net income
Net income -$35.82 -$27.53 -$37.04 -$28.38
Income (for common shares) -$35.82 -$34.72 -$44.09 -$32.7
(in millions $) 30 Sep 2022 30 Jun 2022 31 Mar 2022 31 Dec 2021
Net income -$9.81 -$8.24 -$10.15 -$8.68
Operating activities
Depreciation $0.18 $0.22 $0.21 $0.14
Business acquisitions & disposals
Stock-based compensation $1.68 $1.75 $1.54 $1.5
Total cash flows from operations -$7.14 -$4.14 -$6.52 -$8.96
Investing activities
Capital expenditures -$0.06 -$0.17 -$0
Investments $3.51 $10.11 $3.24 $10.79
Total cash flows from investing $3.46 $9.72 $1.52 $10.79
Financing activities
Dividends paid
Sale and purchase of stock $0.08
Net borrowings
Total cash flows from financing -$0.02 -$0.07 $0.08
Effect of exchange rate
Change in cash and equivalents -$3.7 $5.51 -$5 $1.91
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 30 Dec 2018
Net income -$35.82 -$27.53 -$37.04 -$28.38
Operating activities
Depreciation $0.52 $0.4 $0.3 $0.17
Business acquisitions & disposals
Stock-based compensation $5.38 $1.79 $0.74
Total cash flows from operations -$31.5 -$32.06 -$31.21 -$28.22
Investing activities
Capital expenditures -$0.49 -$1.02 -$0.6 -$1.46
Investments $11.24 -$41.54 -$20.02 -$20.02
Total cash flows from investing $10.75 -$42.56 -$20.62 -$1.46
Financing activities
Dividends paid
Sale and purchase of stock $0.69 $96.33 $0.13
Net borrowings
Total cash flows from financing $0.69 $92.17 $54.87 $42.02
Effect of exchange rate
Change in cash and equivalents -$20.05 $17.55 $3.04 $12.34
Fundamentals
Market cap $14.45M
Enterprise value $4.58M
Shares outstanding 21.56M
Revenue $0.00
EBITDA -$36.13M
EBIT -$36.88M
Net Income -$36.88M
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio -0.39
EV/Sales N/A
EV/EBITDA -0.13
EV/EBIT -0.12
P/S ratio N/A
P/B ratio 0.35
Book/Share 1.93
Cash/Share 0.47
EPS -$1.71
ROA -64.40%
ROE -69.39%
Debt/Equity 0.06
Net debt/EBITDA 0.18
Current ratio 11.98
Quick ratio 11.98